723 related articles for article (PubMed ID: 34108959)
1. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
2. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
3. The CXCR2/CXCL2 signalling pathway - An alternative therapeutic approach in high-grade glioma.
Acker G; Zollfrank J; Jelgersma C; Nieminen-Kelhä M; Kremenetskaia I; Mueller S; Ghori A; Vajkoczy P; Brandenburg S
Eur J Cancer; 2020 Feb; 126():106-115. PubMed ID: 31927212
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma.
Lambertz N; El Hindy N; Kreitschmann-Andermahr I; Stein KP; Dammann P; Oezkan N; Mueller O; Sure U; Zhu Y
BMC Cancer; 2015 Oct; 15():759. PubMed ID: 26490252
[TBL] [Abstract][Full Text] [Related]
5. Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
Nickel AC; Wan XY; Saban DV; Weng YL; Zhang S; Keyvani K; Sure U; Zhu Y
J Neurooncol; 2019 Jan; 141(1):31-41. PubMed ID: 30392087
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Associated Microglia/Macrophages as a Predictor for Survival in Glioblastoma and Temozolomide-Induced Changes in CXCR2 Signaling with New Resistance Overcoming Strategy by Combination Therapy.
Urbantat RM; Jelgersma C; Brandenburg S; Nieminen-Kelhä M; Kremenetskaia I; Zollfrank J; Mueller S; Rubarth K; Koch A; Vajkoczy P; Acker G
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681839
[TBL] [Abstract][Full Text] [Related]
7. PDCD10 promotes the aggressive behaviors of pituitary adenomas by up-regulating CXCR2 and activating downstream AKT/ERK signaling.
Liu J; Wang J; Tian W; Xu Y; Li R; Zhao K; You C; Zhu Y; Bartsch JW; Niu H; Zhang H; Shu K; Lei T
Aging (Albany NY); 2022 Aug; 14(15):6066-6080. PubMed ID: 35963638
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
[TBL] [Abstract][Full Text] [Related]
9. Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221-3p/222-3p axis in glioblastoma.
Malik N; Kundu A; Gupta Y; Irshad K; Arora M; Goswami S; Mahajan S; Sarkar C; Suri V; Suri A; Chattopadhyay P; Sinha S; Chosdol K
Mol Carcinog; 2023 Dec; 62(12):1817-1831. PubMed ID: 37606187
[TBL] [Abstract][Full Text] [Related]
10. The CXCL2/IL8/CXCR2 Pathway Is Relevant for Brain Tumor Malignancy and Endothelial Cell Function.
Urbantat RM; Blank A; Kremenetskaia I; Vajkoczy P; Acker G; Brandenburg S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807899
[TBL] [Abstract][Full Text] [Related]
11. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
[TBL] [Abstract][Full Text] [Related]
12. Combining TMZ and SB225002 induces changes of CXCR2 and VEGFR signalling in primary human endothelial cells
Urbantat RM; Jelgersma C; Vajkoczy P; Brandenburg S; Acker G
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856448
[TBL] [Abstract][Full Text] [Related]
13. CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma.
Angara K; Borin TF; Rashid MH; Lebedyeva I; Ara R; Lin PC; Iskander A; Bollag RJ; Achyut BR; Arbab AS
Neoplasia; 2018 Oct; 20(10):1070-1082. PubMed ID: 30236892
[TBL] [Abstract][Full Text] [Related]
14. Programmed cell death 10 increased blood-brain barrier permeability through HMGB1/TLR4 mediated downregulation of endothelial ZO-1 in glioblastoma.
Wu S; Wang J; Liu J; Zhu H; Li R; Wan X; Lei J; Li Y; You C; Hu F; Zhang S; Zhao K; Shu K; Lei T
Cell Signal; 2023 Jul; 107():110683. PubMed ID: 37075875
[TBL] [Abstract][Full Text] [Related]
15. CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma.
Lepore F; D'Alessandro G; Antonangeli F; Santoro A; Esposito V; Limatola C; Trettel F
Front Immunol; 2018; 9():2750. PubMed ID: 30542347
[TBL] [Abstract][Full Text] [Related]
16. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
[TBL] [Abstract][Full Text] [Related]
17. ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma.
Lailler C; Louandre C; Morisse MC; Lhossein T; Godin C; Lottin M; Constans JM; Chauffert B; Galmiche A; Saidak Z
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467175
[TBL] [Abstract][Full Text] [Related]
18. Exploiting Microglial Functions for the Treatment of Glioblastoma.
Dello Russo C; Lisi L; Tentori L; Navarra P; Graziani G; Combs CK
Curr Cancer Drug Targets; 2017; 17(3):267-281. PubMed ID: 27528361
[TBL] [Abstract][Full Text] [Related]
19. MCP-1 and MIP-3α Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia.
Jung Y; Ahn SH; Park H; Park SH; Choi K; Choi C; Kang JL; Choi YH
Cell Physiol Biochem; 2018; 48(3):1332-1346. PubMed ID: 30048972
[TBL] [Abstract][Full Text] [Related]
20. The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progression.
Ni B; Huang G; Yang R; Wang Z; Song H; Li K; Zhang Y; Wu K; Shi G; Wang X; Shen J; Liu Y
J Neuroinflammation; 2023 Mar; 20(1):80. PubMed ID: 36944954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]